Charles Bancroft has been appointed acting chief financial officer of Bristol-Myers Squibb, effective January 1, 2010. Jean-Marc Huet, executive vice president and chief financial officer, will leave the company at the end of 2009. “Jean-Marc has indicated to me his desire to return to Europe and we wish him every success,” said James M. Cornelius, chairman and chief executive officer of BMS. “The board of directors and I are grateful to Jean-Marc for his strategic work in rapidly and success...